IO Biotech, Inc. (IOBT) Misses Q2 EPS by 3c

IO Biotech, Inc. (NASDAQ: IOBT) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on IO Biotech, Inc. (IOBT) click here.

You May Also Be Interested In

• Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
• RBC Capital Downgrades Dow Inc. (DOW) to Sector Perform
• Prabhudas Lilladher Reiterates Buy (1) Rating on Kotak Mahindra Bank Ltd. (KMB:IN)